Elarcosa, Jesrylle Jhay S.

HRN: 27-43-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/14/2025
07/20/2025
IVT
15mg
Q24
Omphalitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominalDisseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines